Management of atypical glandular cells of undetermined significance pap smears: A reappraisal

Journal of Lower Genital Tract Disease

Volumn 7, Issue 1, 2003, Pages 11-15

  Van Dinh, Tung ^a   Haque, Moona ^a   Lucci III, Joseph A ^a   Smith, Edward R ^a   Hannigan, Edward V ^a  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

Atypical glandular cells; Cervical neoplasia; Pap smear

Indexed keywords

ADENOCARCINOMA; ADULT; AGE; AGED; ARTICLE; BENIGN TUMOR; CLINICAL TRIAL; COLPOSCOPY; CURETTAGE; ENDOMETRIUM BIOPSY; ENDOMETRIUM CARCINOMA; ENDOMETRIUM CYTOLOGY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; NEOPLASM; OVARY CANCER; PAPANICOLAOU TEST; PROSPECTIVE STUDY; RISK FACTOR; UTERINE CERVIX BIOPSY; UTERINE CERVIX CARCINOMA IN SITU; UTERINE ENDOCERVIX;

EID: 0038168821     PISSN: 10892591     EISSN: None     Source Type: Journal    
DOI: 10.1097/00128360-200301000-00004     Document Type: Article

References (23)

1. Eddy GL, Strumpf KB, Wojtowycz MA, Piraino PS,Mazur MT. Biopsy findings in 531 patients with atypical glandular cells of uncertain significance as defined by Bethesda System. Am J Obstet Gynecol 1997;177:1188-95.
2. Jones HW III. Clinical treatment of women with atypical squamous cells of undetermined significance or atypical glandular cells of undetermined significance cervical cytology. Clin Obstet Gynecol 2000;43:381-93.
3. Raab SS, Snider TE, Potts SA, McDaniel HL, Robinson RA, Nelson DL, et al. Atypical glandular cells of undetermined significance. Diagnostic accuracy and interobserver variability using select cytologic criteria. Am J Clin Pathol 1997;107:299-307.
4. Collis S, Sweizig S. Evaluation of atypical glandular cells of uncertain significance on Pap smears. Colposcopist 1995;26:1-3.
5. Kennedy AW, Salmieri SS, Wirth SL, Biscotti CV, Tuason LJ, Travarca MJ. Results of the clinical evaluation of atypical glandular cells of undetermined significance (AGUS) detected on cervical cytology screening. Gynecol Oncol 1996;63:14-8.
6. Zweizig S, Noller K, Reale F, Collis S, Resseguie L. Neoplasia associated with atypical glandular cells of undetermined significance on cervical cytology. Gynecol Oncol 1997;65:314-8.
7. Cox T, AGUS Pap smears: A follow-up strategy. Ob/Gyn Manage 1998;72:87.
8. Veljovich DS, Stoler MH, Andersen WA, Covell JL, Rice LW. Atypical glandular cells of undetermined significance: A five-year retrospective histopathologic study. Am J Obstet Gynecol 1998;179:382-90.
9. Duska LR, Flynn CF, Chen A, Whall-Strojwas D, Goodman A. Clinical evaluation of atypical glandular cells of undetermined significance on cervical cytology. Obstet Gynecol 1998;91:278-82.
10. Korn AP, Judson PL, Zaloudek CJ. Importance of atypical glandular of uncertain significance in cervical cytologic smears. J Reprod Med 1998;43:774-8.
11. Cheng RF, Hernandez E, Anderson LL, Heller PB, Shank R. Clinical significance of a cytologic diagnosis of atypical glandular cells of undetermined significance. J Reprod Med 1999;44:922-8.
12. Dinh TV, Haque M, Gracia JM, Lucci JA III, Smith ER, Hannigan EV. Papanicolaou smears of atypical glandular cells of undetermined significance: Histological correlations and suggestions for management. J Lower Gen Tract Dis 1999;3:73-6.
13. Ronnett BM, Manos MM, Ransley JE, Fetterman BJ, Kinney WK, Hurley LB, et al. Atypical glandular cells of undetermined significance (AGUS): Cytopathologic features, histopathologic results and human Papillomavirus DNA detection. Hum Pathol 1999;30:816-25.
14. Manetta A, Keefe K, Lin F, Ahdoot D, Kaleb V. Atypical glandular cells of undetermined significance in cervical cytologic findings. Am J Obstet Gynecol 1999;180:883-8.
15. Kim TJ, Kim HS, Park CT, Park IS, Hong SR, Park JS, et al. Clinical evaluation of follow-up methods and results of atypical glandular cells of undetermined significance (AGUS) detected on cervicovaginal Pap smears. Gynecol Oncol 1999;73:292-8.
16. Raab SS, Bishop NS, Zaleski MS. Effect of cervical disease history on outcomes of women who have a Pap diagnosis of atypical glandular cells of undetermined sigificance. Gynecol Oncol 1999;74:460-4.
17. Eltabbakh GH, Lipman JN, Mount SL,Morgan A. Significance of atypical glandular cells of undetermined significance on ThinPrep Papanicolaou Smears. Gynecol Oncol 1997;78:245-50.
18. Chhieng DC, Elgert PA, Cingiarella JF, Cohen JM. Clinical significance of atypical glandular cells of undetermined significance. A follow-up study from an academic medical center. Acta Cytol 2000;44:557-66.
19. Chin AB, Bristow RE, Korst LM, Walts A, Lagasse LD. The significance of atypical glandular cells on routine cervical cytologic testing in a community-based population. Am J Obstet Gynecol 2000;182:1278-82.
20. Soofer SB, Sidawy MK. Atypical glandular cells of undetermined significance: Clinically significant lesions and means of patient follow-up. Cancer 2000;90:207-14.
21. Burnett AF. Atypical glandular cell sof undetermined significance Pap smears: Appropriate evaluation and management. Curr Opin Obstet Gynecol 2000;12:33-7.
22. Chhieng DC, Elgert P, Cohen JM, Cangiarella JF. Clinical significance of atypical glandular cells of undetermined significance in postmenopausal women. Cancer 2001;93:1-7.
23. Richart RM, Davey DD, Cox JT, Wright TC. Bethesda 2001: How the new Pap terminology will impact clinical practice. Contemp Ob/Gyn 2001;46,10,15-43.